Clinical Trials Browser

Interventional × Has results × Receptor Protein-Tyrosine Kinases × Clear all

NCT04508725 2025-07-25

Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)

Phase NA Completed

22 enrolled 16 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00373217 2022-09-21

Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Phase 2 Terminated

6 enrolled 9 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03041701 2022-04-14

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

Phase 1/2 Terminated

14 enrolled 17 charts

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT01570036 2020-12-02

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Phase 2 Completed

275 enrolled 23 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01753713 2017-12-12

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Completed

33 enrolled 14 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma